Molecular Drug Targets

Project Period: 2015-03-01 – 2023-02-28
Externally Funded
Acronym
MolTag
Principal Investigator
Gaia Novarino
Department(s)
Novarino Group
Grant Number
W1232-B24
Funding Organisation
FWF

4 Publications

2019 | Journal Article | IST-REx-ID: 7406
Isolation of synaptic vesicles from genetically engineered cultured neurons
C. Mckenzie, M. Spanova, A.J. Johnson, S. Kainrath, V. Zheden, H.H. Sitte, H.L. Janovjak, Journal of Neuroscience Methods 312 (2019) 114–121.
View | DOI | PubMed | Europe PMC
 
2020 | Thesis | IST-REx-ID: 8620
Illuminating the role of Cul3 in autism spectrum disorder pathogenesis
J. Morandell, Illuminating the Role of Cul3 in Autism Spectrum Disorder Pathogenesis, IST Austria, 2020.
View | Files available | DOI
 
2020 | Preprint | IST-REx-ID: 7800 | OA
Cul3 regulates cytoskeleton protein homeostasis and cell migration during a critical window of brain development
J. Morandell, L.A. Schwarz, B. Basilico, S. Tasciyan, A. Nicolas, C.M. Sommer, C. Kreuzinger, L. Knaus, Z. Dobler, E. Cacci, J.G. Danzl, G. Novarino, BioRxiv (n.d.).
View | Files available | Download Preprint (ext.)
 
2020 | Journal Article | IST-REx-ID: 8131 | OA
Molecular mechanisms for targeted ASD treatments
B. Basilico, J. Morandell, G. Novarino, Current Opinion in Genetics and Development 65 (2020) 126–137.
View | Files available | DOI | PubMed | Europe PMC